Background Image
Table of Contents Table of Contents
Previous Page  380 / 658 Next Page
Information
Show Menu
Previous Page 380 / 658 Next Page
Page Background

6

Confirmatory Determination of Buprenorphine and Norbuprenorphine in Urine Using A High-Throughput LC-HRAM-MS/MS Forensic Methodology

Results

Q E ti ™ xac ve

R i

thi LC th d

lti h l

i

MS lt d i

d-MS2 (t-MS2)

unn ng s me o across mu -c anne s us ng one

resu e n a

of 17 500 and

sample cycle time of 1.07 minutes. The method was linear from 5 to 2000

,

l i

li t

ng/mL for both BUP and NBUP with correlation of coefficients (R2) > 0 996

us on s

.

(1/

i hti

i i i

d) d li it f

tit ti

(LOQ) f 5 / L

ect t-MS2

x we g ng; or g n gnore an a m o quan a on

o ng m .

ethod

Figure 3 shows a representative extracted ion chromatogram (XIC) for the

analytes and their respective IS with a mass accuracy of 5 ppm at their LOQ

(5 ng/mL) Table 5 contains a 3 day summary of precision and accuracy in

.

-

the QCs across two LC channels.

t of settings.

Matrix Effects

The absolute recoveries of BUP and NBUP were tested in urine obtained

from six different drug-free human donors as compared to the average in the

Species

water samples (n=3) Absolute recoveries of BUP in these samples ranged

.

from 30 0% to 84 1% and for NBUP from 28 9% to 57 5% at 100 ng/mL The

.

.

.

.

.

l i

i

f BUP d NBUP i h h i

i

IS i

h

H

re at ve recover es o

an

w t t e r respect ve n t ese

+

samples ranged from 90.2% to 111%.

+H

H d l i C t l

y ro ys s on ro

+H

As a result of enzymatic hydrolysis demonstrated here between 98.7% and

113% of expected NBUP was recovered from its glucuronide standard in the

+H

t l ft h d l i

d LC/MS/MS l i b d th ti

f th i

con ro a er y ro ys s an

ana ys s ase on e ra o o e r

molecular weights (0.701).

ed

Figure 3 Representative chromatogram of quan and qual XICs for

.

.

NBUP and its IS at left and for BUP and its IS at right at LOQ (5 ng/mL).

C:\Xcalibur\...\CH1a\SurCal-2-01

05/22/1418:30:18

5.0 cal

RT:

0.00 -0.30

SM:

7G

RT:0.05

AA:57527

NL: 2.46E4

m/z=187 07442 187 07630

RT:

0.00 -0.30

SM:

7G

RT:0.10

AA:5887590

NL: 2.53E6

m/z=187 07442 187 07630

80

100

dance

SN:177

.

-

.

F:FTMS+p ESIFullms2

414.26@hcd

50.00

[50.00-440.00] MS ICIS

SurCal-2-01

80

100

dance

SN:7485

.

-

.

F:FTMS+p ESIFullms2

472.34@hcd

50.00

[50.00-500.00] MS ICIS

SurCal-2-01

40

60

ativeAbund

40

60

ativeAbund

0

20

Relat

RT:0.05

AA:27610

NL: 1.26E4

m/z=211.07430-211.07642

0

20

Relat

RT:0.10

AA:8292683

NL: 3.62E6

m/z=400.24004-400.24404

80

100

ndance

SN:129

F:FTMS+p ESIFullms2

414.26@hcd

50.00

[50.00-440.00] MS ICIS

SurCal-2-01

80

100

ndance

SN:6705

F:FTMS+p ESIFullms2

472.34@hcd

50.00

[50.00-500.00] MS ICIS

SurCal-2-01

20

40

60

ativeAbun

20

40

60

ativeAbun

0

Rela

RT:0.05

AA:5049640

SN 8743

NL: 2.31E6

m/z=187.07442-187.07630

F:FTMS+p ESIFullms2

0

Rela

RT:0.09

AA:65604

SN 74

NL: 2.99E4

m/z=187.07442-187.07630

F:FTMS+p ESIFullms2

60

80

100

undance

:

417.28@hcd

50.00

[50.00-445.00] MS ICIS

SurCal-2-01

60

80

100

undance

:

468.31@hcd

50.00

[50.00-495.00] MS ICIS

SurCal-2-01

20

40

elativeAbu

20

40

elativeAbu

0

Re

RT:0.05

AA:2509319

SN:4462

NL: 1.12E6

m/z=211.07430-211.07642

F:FTMS+p ESIFullms2

0

Re

RT:0.10

AA:83356

SN:165

NL: 3.52E4

m/z=396.21495-396.21891

F:FTMS+p ESIFullms2

60

80

100

bundance

417.28@hcd

50.00

[50.00-445.00] MS ICIS

SurCal-2-01

60

80

100

bundance

468.31@hcd

50.00

[50.00-495.00] MS ICIS

SurCal-2-01

20

40

RelativeAb

20

40

RelativeAb

0.00

0.05

0.10

0.15

0.20

0.25

0.30

Time (min)

0

e

0.00

0.05

0.10

0.15

0.20

0.25

0.30

Time (min)

0

e

T bl 5 I t A (3 d ) P i i

(%CV 5) d A

a e . n er- ssay - ays rec s on

, n= an ccuracy

(%Diff, n=5) obtained by staggered injection across Channel 1 (CH1)

and Channel 2 (CH2) of a Multi-Channel LC.

rties used

QC L l

CH1

CH1

CH2

CH2

.

Analyte

eve

(ng/mL)

%CV

%Diff

%CV %Diff

BUP

10

8 7

7 4

9 7

6 7

.

.

.

.

800

3 3

3 3

4 2

4 4

.

.

.

.